Ashwagandha vs L-Theanine: Which Is Better for Stress?
Both score anxiety 7.5, so the tie-breaker is time. L-theanine works in about an hour and you take it when you need it. Ashwagandha takes eight weeks and…
- Ashwagandha
- L-Theanine
Every intervention Outliyr has scored for deep and rem sleep, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for deep and rem sleep; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
22 of 69 evaluated interventions score 3.0+ out of 10 for deep and rem sleep · 2 comparisons
Glycine sleep architecture earns 7.5/10 because Bannai 2012 anchors the most relevant signal. Glycine fits sleep architecture because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the…
Read the Glycine report →The evidence-weighted call is 6.8/10 for Neurofeedback in sleep architecture, led by Cortese et al. 2016. SMR neurofeedback has a plausible sleep-architecture target and small clinical studies, including Cortoos 2010 in primary…
Read the Neurofeedback report →Evidence from a Cochrane review of nine trials (7111 participants) shows tirzepatide produces modest weight loss versus placebo Franco et al. 2025. Tirzepatide's use-case score for sleep-architecture is 5.8/10, reflecting limited direct…
Read the Tirzepatide report →A 5.5/10 for sleep-architecture fits Zone 2 Cardio because Lang 2024 supports direction more than certainty. The existing rationale points to this narrower claim: Moderate aerobic training can improve sleep architecture over…
Read the Zone 2 Cardio report →Mechanistically, Epitalon scores 5.5/10 for sleep architecture because the evidence points to a plausible use case without proving a universal response. Al-dulaimi et al. 2025 is the best anchor here because it…
Read the Epitalon report →For sleep architecture, Saffron earns 5.0/10 because the evidence points to a plausible use case without proving a universal response. Schuster et al. 2025 is the best anchor here because it reports…
Read the Saffron report →The sleep architecture score is 5.0/10, and L-Theanine needs careful framing. Modest sleep-architecture signal. Lyon 2011 is pediatric ADHD-specific, while Bulman 2025 found objective sleep measures less convincing than subjective sleep outcomes.…
Read the L-Theanine report →Sleep-architecture is 5.0/10 because Semaglutide may improve apnea-driven sleep fragmentation through weight loss, but this report has no strong polysomnography architecture endpoint. Kosiborod 2024 supports symptom improvement in obesity-related HFpEF with diabetes,…
Read the Semaglutide report →The sleep architecture case for CJC-1295 is 5.0/10 because Teichman 2006 reports CJC-1295 human pharmacology; supports sustained GH/IGF-1 increase and short-duration tolerability, not body-composition or longevity outcomes. Ionescu 2006 points in the…
Read the CJC-1295 report →No direct sleep architecture trial was verified for EAA supplementation. Any sleep effect is indirect through training recovery, appetite stability, or tryptophan competition rather than measured REM, deep sleep, or awakenings.
Read the Essential Amino Acids report →Yamadera 2007 used polysomnography and reported sleep-efficiency and slow-wave-sleep changes with 3 g glycine. Collagen is an indirect glycine vehicle.
Read the Collagen Peptides report →No direct polysomnography, wearable sleep-stage, or sleep-architecture trial was found. Any sleep effect should be treated as secondary to cortisol timing and arousal state.
Read the Tongkat Ali report →No direct sleep-architecture evidence exists. Metformin is not a sleep-stage intervention.
Read the Metformin report →Sleep architecture earns a moderate score because Langade 2019 included objective sleep assessment and Cheah 2021 supports a sleep meta-analysis signal. Evidence is better than most adaptogens but not comparable to full…
Read the Ashwagandha report →Sleep-stage evidence is thin. Community reports of more deep sleep after keto adaptation exist, but polysomnography data is not strong enough to score higher. Early restriction can reduce sleep continuity, and long-term…
Read the Ketogenic Diet report →No direct evidence on REM, deep sleep, sleep latency, or sleep efficiency. Score stays below neutral because the mechanism does not map cleanly to sleep architecture.
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report →INSUFFICIENT_EVIDENCE for sleep architecture; any sleep tracking should be safety and response monitoring only.
Read the Rapamycin report →No direct sleep-architecture evidence. Any effect would likely come through training fatigue, pain reduction, or mobility gains rather than a primary sleep mechanism.
Read the Whole-Body Vibration report →Bedtime dosing tries to amplify the natural slow-wave-sleep GH pulse. The timing logic is coherent, but controlled sleep-architecture endpoints with tesamorelin have not established a robust clinical effect.
Read the Tesamorelin report →Fitness may improve slow-wave sleep over time. Late sessions can disrupt sleep architecture in sensitive users, so this remains timing-dependent.
Read the Norwegian 4×4 report →Vivid dreams suggest REM-stage effects for some users, but no polysomnography study confirms sleep-architecture changes. Keep this as anecdotal until objective sleep-stage data exist.
Read the Lion’s Mane report →TRT has no clear sleep-architecture benefit and can worsen sleep apnea. Men with snoring, daytime sleepiness, high hematocrit, or resistant hypertension need sleep evaluation before dose escalation.
Read the TRT (Testosterone Replacement Therapy) report →Nothing matches those filters.
Head-to-head reports and category rankings that name a winner on this use case.
Both score anxiety 7.5, so the tie-breaker is time. L-theanine works in about an hour and you take it when you need it. Ashwagandha takes eight weeks and…
Tesamorelin, unless price is the only thing deciding. It is FDA-approved for visceral fat with Phase 3 trials behind it, while CJC-1295 is a gray-market research peptide whose…
Glycine, at 7.5 out of 10 for deep and rem sleep. Glycine sleep architecture earns 7.5/10 because Bannai 2012 anchors the most relevant signal.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 7.5 out of 10 for deep and rem sleep.
22 of the 69 interventions evaluated for deep and rem sleep score 3.0 out of 10 or better, which is the cut-off for appearing on this page.